Levels of GPBB, cTn-I and CK-MB before and after treatment: The levels of GPBB, cTn-I and CK-MB in the observation group were significantly higher than those of normal neonates (P<0.01).
Table-II: Levels of GPBB, cTn-I and CK-MB before and after treatment in two groups (x+-s).
Table-III: Levels of GPBB, cTn-I and CK-MB before and after treatment according to degree of asphyxia (x+-s).
The results showed that the levels of GPBB, cTn-I and CK-MB were the highest in the severe asphyxia group, and the values of the mild asphyxia group were lower compared with the former group, but the values of both groups were higher than those of normal neonates.
GPBB is an early biochemical marker found in recent years that can reflect the hypoxia and ischemia of brain cells and myocardial cells.
 and GPBB --have been analyzed for the clinical diagnosis of myocardial ischemia within the first 1-3 h after the onset of chest pain.
In this study, we found that GPBB was the most sensitive and specific biomarker to detect myocardial infarction when compared to MB and CKMB at the first 4 h (Table 2).
ROC curve analysis showed GPBB had the highest area under curve followed by MB and CKMB (Table 3).
GPBB was the most sensitive and specific cardiac marker compared to other tested cardiac markers MB and CKMB in AMI patients during the first 4 h after the onset of chest pain.
Diagnostic accuracy of heart fatty acid binding protein (H-FABP) and glycogen phosphorylase isoenzyme BB (GPBB) in diagnosis of acute myocardial infarction in patients with acute coronary syndrome.